Dock Street Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Dock Street Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$548.35 - $738.84 $29,062 - $39,158	-53 Reduced 0.78%	6,715 $3.97 Million
Q1 2022 Apr 14, 2022	SELL	$595.12 - $698.43 $45,229 - $53,080	-76 Reduced 1.11%	6,768 $4.73 Million
Q4 2021 Jan 14, 2022	BUY	$543.48 - $670.97 $64,674 - $79,845	119 Added 1.77%	6,844 $4.32 Million
Q3 2021 Oct 26, 2021	BUY	$574.03 - $680.96 $23,535 - $27,919	41 Added 0.61%	6,725 $4.07 Million
Q2 2021 Jul 15, 2021	SELL	$472.8 - $558.54 $498,804 - $589,259	-1,055 Reduced 13.63%	6,684 $3.73 Million
Q1 2021 Apr 15, 2021	BUY	$446.73 - $548.2 $68,796 - $84,422	154 Added 2.03%	7,739 $3.66 Million
Q4 2020 Jan 27, 2021	BUY	$478.3 - $607.98 $3.63 Million - $4.61 Million	7,585 New	7,585 $3.66 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Dock Street Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Dock Street Asset Management Inc with notifications on news.